Literature DB >> 7582305

Influence of sleep on ventilatory and upper airway response to CO2 in normal subjects and patients with COPD.

J C Meurice1, I Marc, F Sériès.   

Abstract

In order to investigate the influence of the dynamic changes in upper airway (UA) resistance in the pathophysiology of noctural hypoventilation in COPD, we compared the ventilatory pattern and UA resistance, measured at baseline and during CO2 rebreathing, in nine normal men and 13 patients with COPD. Measurements were made during wakefulness and during non-REM sleep during a morning nap after a sleep deprivation night. Ventilatory parameters (VE, VT, VT/TI) were calculated from flow measurements using a Fleich no. 3 pneumotachograph connected to a fitting nasal mask. Pharyngeal pressure was measured with a low-bias catheter referenced to the mask pressure. Baseline UA resistances (supraglottic resistance: SGR) values were similar in the two groups. They significantly increased in both groups from wakefulness to sleep. Furthermore, VE and VT/TI were higher in patients with COPD than in normal subjects during wakefulness and during sleep. The slope of the VE/PETCO2 relationship was significantly lower in patients with COPD than in normal subjects (p = 0.0001), without any significant decrease between wakefulness and sleep. SGR systematically decreased during CO2 rebreathing in both groups during wakefulness and during sleep. The slope of SGR/PETCO2 relationship was lower in patients with COPD than in control subjects during sleep and during wakefulness (p = 0.005), whereas the decrease in SGR with increased VE and VT/TI was similar in both groups and not influenced by sleep. We conclude that the impediment in UA resistance behavior in response to a hypercapnic stimulus in patients with COPD is related to the decrease in their ventilatory response.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7582305     DOI: 10.1164/ajrccm.152.5.7582305

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  8 in total

1.  Sleep and Obstructive Lung Diseases.

Authors:  Michael E Ezzie; Jonathan P Parsons; John G Mastronarde
Journal:  Sleep Med Clin       Date:  2008-12

2.  Neural respiratory drive and ventilation in patients with chronic obstructive pulmonary disease during sleep.

Authors:  Yuan-Ming Luo; Bai-Ting He; Yin-Xin Wu; Hong Yuan; Jing Xu; John Moxham; Michael Polkey
Journal:  Am J Respir Crit Care Med       Date:  2014-07-15       Impact factor: 21.405

3.  Effects of stabilizing or increasing respiratory motor outputs on obstructive sleep apnea.

Authors:  Ailiang Xie; Mihaela Teodorescu; David F Pegelow; Mihai C Teodorescu; Yuansheng Gong; Jessica E Fedie; Jerome A Dempsey
Journal:  J Appl Physiol (1985)       Date:  2013-04-18

4.  Changes in respiration in NREM sleep in hypercapnic chronic obstructive pulmonary disease.

Authors:  Fergal J O'Donoghue; Peter G Catcheside; Danny J Eckert; R Doug McEvoy
Journal:  J Physiol       Date:  2004-07-02       Impact factor: 5.182

5.  Expiratory Time Constant and Sleep Apnea Severity in the Overlap Syndrome.

Authors:  Darunee Wiriyaporn; Lu Wang; Loutfi S Aboussouan
Journal:  J Clin Sleep Med       Date:  2016-03       Impact factor: 4.062

6.  Coexistence of OSA may compensate for sleep related reduction in neural respiratory drive in patients with COPD.

Authors:  Bai-Ting He; Gan Lu; Si-Chang Xiao; Rui Chen; Joerg Steier; John Moxham; Michael I Polkey; Yuan-Ming Luo
Journal:  Thorax       Date:  2016-11-02       Impact factor: 9.139

7.  Pathogenesis of obstructive sleep apnea in individuals with the COPD + OSA Overlap syndrome versus OSA alone.

Authors:  Jeremy E Orr; Christopher N Schmickl; Bradley A Edwards; Pamela N DeYoung; Rebbecca Brena; Xiaoying S Sun; Sonia Jain; Atul Malhotra; Robert L Owens
Journal:  Physiol Rep       Date:  2020-02

Review 8.  Sleep disordered breathing and chronic obstructive pulmonary disease: a narrative review on classification, pathophysiology and clinical outcomes.

Authors:  Rebecca F D'Cruz; Patrick B Murphy; Georgios Kaltsakas
Journal:  J Thorac Dis       Date:  2020-10       Impact factor: 2.895

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.